Zdrowie i gospodarka · 04/01/2018

FDA Releases Draft Guidance for Abbreviated New Drug Application Submission Practices

The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies prepare and submit abbreviated new drug applications (ANDAs) to the FDA, aiming to reduce delays in approval by identifying and addressing common deficiencies in the submission process.